Why the study?
Does Björk-Shiley disc valve replacement provide safe and effective outcomes in children under 10 years of age?
Does Björk-Shiley disc valve replacement provide safe and effective outcomes in children under 10 years of age?
Answers are grounded in this paper and cite their sources.
The use of the Björk-Shiley disc valve in young children appears safe and effective, with no deaths or thromboembolic events observed over 155 patient-months.
Five children under 10 years of age were operated on with a Björk-Shiley disc valve. The mitral valve was replaced in four patients and the tricuspid valve in one. No hospital death, late death or thromboembolic episode was observed during the 155 patient-months of the follow-up. Moreover, a marked reduction in cardiomegaly was demonstrated to parallel the clinical improvement and low risk seen in adults. We feel that our experience might justify a more aggressive approach in the management of valvular disease in children of the younger age group.
No takes yet. Share an insight, caveat, or question.
Nonoyama et al. (1977) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: